Alliqua BioMedical Inc buy krebskrebs
Start price
03.05.20
/
50%
€0.33
Target price
04.11.21
€0.50
Performance (%)
-84.85%
End price
05.11.21
€0.050
Summary
This prediction ended on 05.11.21 with a price of €0.050. The BUY prediction by krebskrebs for Alliqua BioMedical Inc performed very badly with a performance of -84.85%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alliqua BioMedical Inc | - | - | - | - |
iShares Core DAX® | 1.560% | 4.721% | 18.671% | 17.397% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% | 35.896% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% | 10.295% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% | 38.843% |
Comments by krebskrebs for this prediction
In the thread Alliqua BioMedical Inc diskutieren
Buy mit Kursziel 0,5
In the thread Trading Alliqua BioMedical Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten